Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05049291 · ClinicalTrials.gov registry record · NA

Pilot Study of an Advance Care Planning Intervention Among Persons With Dementia

A NA study, sponsored by Oregon Health and Science University.

Completed
Registry status
NA
Development phase
13
Enrollment target

NCT05049291: Completed NA study, sponsored by Oregon Health and Science University.

NCT05049291 is a NA study that has completed, run by Oregon Health and Science University. The registered enrollment target is 13 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05049291, a NA study, has completed, sponsored by Oregon Health and Science University.

COMPLETED
Registry status
NA
Development phase
13 participants
Enrollment target

Study Summary

Advance care planning allows people to have their wishes taken into account even in the advanced stages of the persons' condition and at the end of life when the person may be unable to communicate. However, a recent review found an absence of high-quality guidelines for advanced care planning in dementia care. Since few evidence-based resources exist, the investigators propose a study to generate, refine, and pilot test an education information sheet designed to promote advanced care planning among families of persons with dementia.

Primary Outcome

Feasibility of the information sheet is defined as the consent rate of family members who are offered enrollment. This will be calculatd as a percent of family members (number of enrolled participants/number of eligible participants offered enrollment)

Interventions

  • BEHAVIORAL telehealth advance care planning

Trial Details

FieldValue
Enrollment Target 13 participants
Start Date 2022-11-10
Est. Completion 2023-07-18
Phase NA

What the finished NCT05049291 record still lists

NCT05049291 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 1 intervention - of which telehealth advance care planning is the first listed.

NCT05049291 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT05049291 about?

NCT05049291 is a clinical study titled "Pilot Study of an Advance Care Planning Intervention Among Persons With Dementia". Advance care planning allows people to have their wishes taken into account even in the advanced stages of the persons' condition and at the end of life when the person may be unable to communicate. However, a recent review found an absence of high-quality guidelines for advanced care planning in de...

What is the current status of trial NCT05049291?

This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2022-11-10. Estimated completion is 2023-07-18.

What interventions are being tested in trial NCT05049291?

The interventions under investigation include: telehealth advance care planning (BEHAVIORAL).

Who is sponsoring clinical trial NCT05049291?

This trial is sponsored by Oregon Health and Science University, which has 546 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT05049291's enrollment target sits among peer trials

13 1911th of 2000 higher than 88 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03125655 · 13 participants

    Regulation of Inflammatory Genes in Psoriasis

  • NCT03774446 · 13 participants · Phase 2

    Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease

  • NCT03830151 · 13 participants · Phase 1

    Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors

  • NCT04573231 · 13 participants · Phase 2

    Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05049291, the US trial registry maintained by the National Library of Medicine. NCT05049291 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.